Iktos
Fabien Guillemot currently serves as CFO at iktos since December 2024 and as a Startup Mentor at Graines de Boss since January 2022. Previously, Fabien held the position of Finance Director at Depixus from February 2022 to July 2025 and co-founded Placr, which gained over 30,000 users, in September 2018, continuing until July 2024. Fabien also worked as Chief Financial Officer at ROCHER PARTICIPATIONS from November 2019 to February 2022 and co-founded BoostYourFit from November 2016 to June 2020. Additional experience includes serving as Group Controller at SES-imagotag, Head of Controlling at Oberthur Technologies, and Manager in Transaction Services at PwC France. Fabien began the professional career as an intern at Mazars in 2004. Education includes studies at EM Strasbourg Business School and ISEG.
This person is not in any teams
This person is not in any offices
Iktos
Incorporated in October 2016, Iktos is a start-up company specializing in the development of artificial intelligence solutions applied to chemical research, more specifically medicinal chemistry and new drug design. Iktos is developing a proprietary and innovative solution based on deep learning generative models, which enables, using existingdata, the design of molecules that are optimized in silico to meet all the success criteria of a small molecule discovery project. The use of Iktos technology enables major productivity gains in upstream pharmaceutical R&D. Iktos offers its technology both as a professional services and as a SaaS software platform. Iktos offers Makya™, ligand and structure-based de novo drug design platform for multi-parametric optimisation (MPO) of lead compounds in line with Target Candidate Profile (TCP). Iktos is also developing Spaya™, a synthesis planning software based upon Iktos’s proprietary AI technology for retrosynthesis.